JOHNSON & JOHNSON DEVELOPMENT CORP ET AL
Insider CIK 924020 · ACHN 10% owner · CVRX 10% owner · ALDX 10% owner · PTGX 10% owner · AQXP 10% owner · NVRO 10% owner · GNCA 10% owner · NERV 10% owner · INSP 10% owner · PRVB 10% owner · MGTX 10% owner · FUSN 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CVRX CVRx, Inc. | S Sale | 2025-11-26 | 2026-01-08 | 6,337 | $10.03 | $63.6K | 4,024,861 | SEC↗ |
| CVRX CVRx, Inc. | S Sale | 2025-11-26 | 2025-12-01 | 6,337 | $10.03 | $63.6K | 4,040,861 | SEC↗ |
| CVRX CVRx, Inc. | S Sale | 2025-11-25 | 2026-01-08 | 16,000 | $10.03 | $160.5K | 4,031,198 | SEC↗ |
| CVRX CVRx, Inc. | S Sale | 2025-11-24 | 2025-11-25 | 2,200 | $10.06 | $22.1K | 4,047,198 | SEC↗ |
| CVRX CVRx, Inc. | S Sale | 2025-11-21 | 2025-11-25 | 500 | $10.00 | $5.0K | 4,049,398 | SEC↗ |
| CVRX CVRx, Inc. | S Sale | 2025-11-12 | 2025-11-14 | 1,000 | $10.00 | $10.0K | 4,049,898 | SEC↗ |
| CVRX CVRx, Inc. | S Sale | 2025-11-07 | 2025-11-10 | 200 | $10.00 | $2.0K | 4,050,898 | SEC↗ |
| CVRX CVRx, Inc. | S Sale | 2025-11-06 | 2025-11-10 | 52,332 | $10.21 | $534.3K | 4,051,098 | SEC↗ |
| CVRX CVRx, Inc. | M Exercise deriv | 2024-02-29 | 2024-03-06 | 118 | — | $0 | 0 | SEC↗ |
| CVRX CVRx, Inc. | M Exercise deriv | 2024-02-29 | 2024-03-06 | 165 | — | $0 | 0 | SEC↗ |
| CVRX CVRx, Inc. | M Exercise deriv | 2024-02-29 | 2024-03-06 | 189 | — | $0 | 0 | SEC↗ |
| CVRX CVRx, Inc. | M Exercise deriv | 2024-02-29 | 2024-03-06 | 158 | — | $0 | 0 | SEC↗ |
| CVRX CVRx, Inc. | M Exercise deriv | 2024-02-29 | 2024-03-06 | 23 | — | $0 | 0 | SEC↗ |
| CVRX CVRx, Inc. | M Exercise deriv | 2024-02-29 | 2024-03-06 | 758 | — | $0 | 0 | SEC↗ |
| CVRX CVRx, Inc. | M Exercise deriv | 2024-02-29 | 2024-03-06 | 85 | — | $0 | 0 | SEC↗ |
| CVRX CVRx, Inc. | M Exercise deriv | 2024-02-29 | 2024-03-06 | 79 | — | $0 | 0 | SEC↗ |
| CVRX CVRx, Inc. | M Exercise deriv | 2024-02-29 | 2024-03-06 | 252 | — | $0 | 0 | SEC↗ |
| CVRX CVRx, Inc. | M Exercise deriv | 2024-02-29 | 2024-03-06 | 142 | — | $0 | 0 | SEC↗ |
| CVRX CVRx, Inc. | M Exercise deriv | 2024-02-29 | 2024-03-06 | 442 | — | $0 | 0 | SEC↗ |
| CVRX CVRx, Inc. | M Exercise deriv | 2024-02-29 | 2024-03-06 | 300 | — | $0 | 0 | SEC↗ |
| CVRX CVRx, Inc. | M Exercise deriv | 2024-02-29 | 2024-03-06 | 584 | — | $0 | 0 | SEC↗ |
| CVRX CVRx, Inc. | M Exercise deriv | 2024-02-29 | 2024-03-06 | 489 | — | $0 | 0 | SEC↗ |
| CVRX CVRx, Inc. | M Exercise deriv | 2024-02-29 | 2024-03-06 | 71 | — | $0 | 0 | SEC↗ |
| CVRX CVRx, Inc. | M Exercise | 2024-02-29 | 2024-03-06 | 79 | $5.14 | $406 | 4,103,430 | SEC↗ |
| CVRX CVRx, Inc. | M Exercise | 2024-02-29 | 2024-03-06 | 158 | $0.24 | $38 | 4,099,733 | SEC↗ |
| CVRX CVRx, Inc. | M Exercise | 2024-02-29 | 2024-03-06 | 189 | $0.24 | $45 | 4,099,922 | SEC↗ |
| CVRX CVRx, Inc. | M Exercise | 2024-02-29 | 2024-03-06 | 165 | $0.24 | $40 | 4,100,087 | SEC↗ |
| CVRX CVRx, Inc. | M Exercise | 2024-02-29 | 2024-03-06 | 118 | $0.24 | $28 | 4,100,205 | SEC↗ |
| CVRX CVRx, Inc. | M Exercise | 2024-02-29 | 2024-03-06 | 71 | $0.24 | $17 | 4,100,276 | SEC↗ |
| CVRX CVRx, Inc. | M Exercise | 2024-02-29 | 2024-03-06 | 23 | $0.24 | $6 | 4,100,299 | SEC↗ |
| CVRX CVRx, Inc. | M Exercise | 2024-02-29 | 2024-03-06 | 85 | $0.24 | $20 | 4,100,384 | SEC↗ |
| CVRX CVRx, Inc. | M Exercise | 2024-02-29 | 2024-03-06 | 758 | $0.24 | $182 | 4,101,142 | SEC↗ |
| CVRX CVRx, Inc. | M Exercise | 2024-02-29 | 2024-03-06 | 489 | $0.24 | $117 | 4,101,631 | SEC↗ |
| CVRX CVRx, Inc. | M Exercise | 2024-02-29 | 2024-03-06 | 584 | $0.24 | $140 | 4,102,215 | SEC↗ |
| CVRX CVRx, Inc. | M Exercise | 2024-02-29 | 2024-03-06 | 300 | $0.24 | $72 | 4,102,515 | SEC↗ |
| CVRX CVRx, Inc. | M Exercise | 2024-02-29 | 2024-03-06 | 442 | $1.19 | $526 | 4,102,957 | SEC↗ |
| CVRX CVRx, Inc. | M Exercise | 2024-02-29 | 2024-03-06 | 252 | $3.96 | $998 | 4,103,351 | SEC↗ |
| CVRX CVRx, Inc. | M Exercise | 2024-02-29 | 2024-03-06 | 142 | $1.19 | $169 | 4,103,099 | SEC↗ |
| CVRX CVRx, Inc. | X Exercise deriv | 2024-02-16 | 2024-03-06 | 607,225 | — | $0 | 0 | SEC↗ |
| CVRX CVRx, Inc. | X Exercise | 2024-02-16 | 2024-03-06 | 607,725 | $0.16 | $97.2K | 4,103,300 | SEC↗ |
| CVRX CVRx, Inc. | S Sale | 2024-02-16 | 2024-03-06 | 3,725 | $25.81 | $96.1K | 4,099,575 | SEC↗ |
| CVRX CVRx, Inc. | J Other deriv | 2023-09-15 | 2024-02-02 | 758 | — | $0 | 0 | SEC↗ |
| CVRX CVRx, Inc. | J Other deriv | 2023-09-15 | 2024-02-02 | 489 | — | $0 | 0 | SEC↗ |
| CVRX CVRx, Inc. | J Other deriv | 2023-09-15 | 2024-02-02 | 758 | — | $0 | 0 | SEC↗ |
| CVRX CVRx, Inc. | J Other deriv | 2023-09-15 | 2024-02-02 | 85 | — | $0 | 0 | SEC↗ |
| CVRX CVRx, Inc. | J Other deriv | 2023-09-15 | 2024-02-02 | 23 | — | $0 | 0 | SEC↗ |
| CVRX CVRx, Inc. | J Other deriv | 2023-09-15 | 2024-02-02 | 71 | — | $0 | 0 | SEC↗ |
| CVRX CVRx, Inc. | J Other deriv | 2023-09-15 | 2024-02-02 | 118 | — | $0 | 0 | SEC↗ |
| CVRX CVRx, Inc. | J Other deriv | 2023-09-15 | 2024-02-02 | 165 | — | $0 | 0 | SEC↗ |
| CVRX CVRx, Inc. | J Other deriv | 2023-09-15 | 2024-02-02 | 189 | — | $0 | 0 | SEC↗ |
| CVRX CVRx, Inc. | J Other deriv | 2023-09-15 | 2024-02-02 | 158 | — | $0 | 0 | SEC↗ |
| CVRX CVRx, Inc. | J Other deriv | 2023-09-15 | 2024-02-02 | 237 | — | $0 | 0 | SEC↗ |
| CVRX CVRx, Inc. | J Other deriv | 2023-09-15 | 2024-02-02 | 1,264 | — | $0 | 0 | SEC↗ |
| CVRX CVRx, Inc. | J Other deriv | 2023-09-15 | 2024-02-02 | 758 | — | $0 | 0 | SEC↗ |
| CVRX CVRx, Inc. | J Other deriv | 2023-09-15 | 2024-02-02 | 142 | — | $0 | 0 | SEC↗ |
| CVRX CVRx, Inc. | J Other deriv | 2023-09-15 | 2024-02-02 | 758 | — | $0 | 0 | SEC↗ |
| CVRX CVRx, Inc. | J Other deriv | 2023-09-15 | 2024-02-02 | 300 | — | $0 | 0 | SEC↗ |
| CVRX CVRx, Inc. | J Other | 2023-09-15 | 2023-09-18 | 3,495,575 | — | $0 | 0 | SEC↗ |
| MGTX MeiraGTx Holdings plc | J Other | 2023-09-15 | 2023-09-18 | 6,641,064 | — | $0 | 0 | SEC↗ |
| CVRX CVRx, Inc. | C Conversion deriv | 2021-07-02 | 2021-07-02 | 7,587,828 | — | $0 | 0 | SEC↗ |
| CVRX CVRx, Inc. | C Conversion deriv | 2021-07-02 | 2021-07-02 | 48,068,690 | — | $0 | 0 | SEC↗ |
| CVRX CVRx, Inc. | C Conversion deriv | 2021-07-02 | 2021-07-02 | 4,032,259 | — | $0 | 0 | SEC↗ |
| CVRX CVRx, Inc. | C Conversion deriv | 2021-07-02 | 2021-07-02 | 6,451,188 | — | $0 | 0 | SEC↗ |
| CVRX CVRx, Inc. | C Conversion | 2021-07-02 | 2021-07-02 | 3,495,575 | — | $0 | 3,495,575 | SEC↗ |
| FUSN Fusion Pharmaceuticals Inc | C Conversion deriv | 2020-06-30 | 2020-07-02 | 10,666,667 | — | $0 | 0 | SEC↗ |
| FUSN Fusion Pharmaceuticals Inc | C Conversion deriv | 2020-06-30 | 2020-07-02 | 5,059,460 | — | $0 | 0 | SEC↗ |
| FUSN Fusion Pharmaceuticals Inc | C Conversion deriv | 2020-06-30 | 2020-07-02 | 89,118 | — | $0 | 89,118 | SEC↗ |
| FUSN Fusion Pharmaceuticals Inc | C Conversion deriv | 2020-06-30 | 2020-07-02 | 475,802 | — | $0 | 0 | SEC↗ |
| FUSN Fusion Pharmaceuticals Inc | C Conversion | 2020-06-30 | 2020-07-02 | 2,945,516 | — | $0 | 2,945,516 | SEC↗ |
| FUSN Fusion Pharmaceuticals Inc | P Buy | 2020-06-30 | 2020-07-02 | 725,000 | $17.00 | $12.32M | 3,670,516 | SEC↗ |
| PRVB Provention Bio, Inc. | C Conversion deriv | 2018-07-19 | 2018-07-20 | 2,400,000 | — | $0 | 0 | SEC↗ |
| PRVB Provention Bio, Inc. | C Conversion | 2018-07-19 | 2018-07-20 | 2,400,000 | — | $0 | 2,400,000 | SEC↗ |
| INSP Inspire Medical Systems, I | C Conversion deriv | 2018-05-07 | 2018-05-07 | 248,631 | — | $0 | 0 | SEC↗ |
| INSP Inspire Medical Systems, I | C Conversion deriv | 2018-05-07 | 2018-05-07 | 1,145,038 | — | $0 | 0 | SEC↗ |
| INSP Inspire Medical Systems, I | C Conversion | 2018-05-07 | 2018-05-07 | 197,863 | — | $0 | 197,863 | SEC↗ |
| INSP Inspire Medical Systems, I | C Conversion | 2018-05-07 | 2018-05-07 | 37,388 | — | $0 | 235,251 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | S Sale | 2017-11-20 | 2017-11-22 | 18,367,346 | $2.75 | $50.51M | 0 | SEC↗ |
| NERV Minerva Neurosciences, Inc | J Other | 2017-08-29 | 2017-09-14 | 3,892,256 | — | $0 | 0 | SEC↗ |
| PTGX Protagonist Therapeutics, | C Conversion deriv | 2016-08-16 | 2016-08-18 | 13,054,830 | — | $0 | 0 | SEC↗ |
| PTGX Protagonist Therapeutics, | C Conversion deriv | 2016-08-16 | 2016-08-18 | 14,000,000 | — | $0 | 0 | SEC↗ |
| PTGX Protagonist Therapeutics, | C Conversion | 2016-08-16 | 2016-08-18 | 900,333 | — | $0 | 1,865,850 | SEC↗ |
| PTGX Protagonist Therapeutics, | P Buy | 2016-08-16 | 2016-08-18 | 583,333 | $12.00 | $7.00M | 2,449,183 | SEC↗ |
| PTGX Protagonist Therapeutics, | C Conversion | 2016-08-16 | 2016-08-18 | 965,517 | — | $0 | 965,517 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | S Sale | 2015-08-11 | 2015-08-12 | 1,283,366 | $20.74 | $26.62M | 100,000 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | S Sale | 2015-08-10 | 2015-08-12 | 231,455 | $31.66 | $7.33M | 1,383,366 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2015-06-08 | 2015-06-08 | 1,010,265 | $47.94 | $48.43M | 2,066,740 | SEC↗ |
| NERV Minerva Neurosciences, Inc | P Buy deriv | 2015-03-13 | 2015-03-17 | 607,903 | $0.13 | $79.0K | 607,903 | SEC↗ |
| NERV Minerva Neurosciences, Inc | P Buy | 2015-03-13 | 2015-03-17 | 607,903 | $4.81 | $2.92M | 4,500,159 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | S Sale | 2014-12-17 | 2014-12-18 | 1,593 | $7.58 | $12.1K | 1,342,094 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | S Sale | 2014-12-16 | 2014-12-18 | 6,507 | $7.63 | $49.6K | 1,343,687 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | S Sale | 2014-12-12 | 2014-12-15 | 3,645 | $7.51 | $27.4K | 1,350,194 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | S Sale | 2014-12-11 | 2014-12-15 | 1,355 | $7.50 | $10.2K | 1,353,839 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | S Sale | 2014-12-10 | 2014-12-10 | 1,300 | $7.70 | $10.0K | 1,355,194 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | S Sale | 2014-12-09 | 2014-12-10 | 5,000 | $7.73 | $38.6K | 1,356,494 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | S Sale | 2014-12-08 | 2014-12-10 | 2,000 | $7.69 | $15.4K | 1,361,494 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | S Sale | 2014-12-05 | 2014-12-05 | 4,200 | $7.78 | $32.7K | 1,363,494 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | S Sale | 2014-12-04 | 2014-12-05 | 10,073 | $7.76 | $78.2K | 1,367,694 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | S Sale | 2014-12-03 | 2014-12-05 | 1,627 | $7.75 | $12.6K | 1,377,767 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | S Sale | 2014-12-01 | 2014-12-03 | 1,200 | $7.54 | $9.0K | 1,379,394 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | S Sale | 2014-11-26 | 2014-11-26 | 500 | $7.60 | $3.8K | 1,380,594 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | S Sale | 2014-11-25 | 2014-11-26 | 1,500 | $7.80 | $11.7K | 1,381,094 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | S Sale | 2014-11-24 | 2014-11-24 | 4,000 | $8.02 | $32.1K | 1,382,594 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | S Sale | 2014-11-21 | 2014-11-24 | 2,400 | $8.25 | $19.8K | 1,386,594 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | S Sale | 2014-11-20 | 2014-11-24 | 3,100 | $8.21 | $25.5K | 1,388,994 | SEC↗ |
| NVRO NEVRO CORP | C Conversion deriv | 2014-11-12 | 2014-11-12 | 246,827 | — | $0 | 0 | SEC↗ |
| NVRO NEVRO CORP | C Conversion deriv | 2014-11-12 | 2014-11-12 | 2,790,178 | — | $0 | 0 | SEC↗ |
| NVRO NEVRO CORP | C Conversion | 2014-11-12 | 2014-11-12 | 3,037,005 | — | $0 | 3,037,005 | SEC↗ |
| NVRO NEVRO CORP | P Buy | 2014-11-12 | 2014-11-12 | 40,000 | $18.00 | $720.0K | 3,077,005 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | C Conversion deriv | 2014-05-01 | 2014-05-05 | 385,800 | — | $0 | 0 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | C Conversion deriv | 2014-05-01 | 2014-05-05 | 104,396 | — | $0 | 0 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | C Conversion deriv | 2014-05-01 | 2014-05-05 | 427,591 | — | $0 | 0 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | C Conversion deriv | 2014-05-01 | 2014-05-05 | 133,827 | — | $0 | 0 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | M Exercise deriv | 2014-05-01 | 2014-05-05 | 36,345 | — | $0 | 0 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | M Exercise deriv | 2014-05-01 | 2014-05-05 | 36,345 | — | $0 | 0 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | F Tax w/h | 2014-05-01 | 2014-05-05 | 23,438 | $8.00 | $187.5K | 1,737,385 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | M Exercise | 2014-05-01 | 2014-05-05 | 36,345 | $5.16 | $187.5K | 1,773,730 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | F Tax w/h | 2014-05-01 | 2014-05-05 | 23,438 | $8.00 | $187.5K | 1,750,292 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | M Exercise | 2014-05-01 | 2014-05-05 | 36,345 | $5.16 | $187.5K | 1,760,823 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | C Conversion | 2014-05-01 | 2014-05-05 | 1,724,478 | — | $0 | 1,724,478 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | C Conversion deriv | 2014-03-12 | 2015-02-03 | 170,454 | — | $0 | 0 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | C Conversion deriv | 2014-03-12 | 2015-02-03 | 379,543 | — | $0 | 0 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | C Conversion deriv | 2014-03-12 | 2015-02-03 | 292,532 | — | $0 | 0 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | C Conversion deriv | 2014-03-12 | 2015-02-03 | 293,884 | — | $0 | 0 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | C Conversion deriv | 2014-03-12 | 2015-02-03 | 255,681 | — | $0 | 0 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | C Conversion | 2014-03-12 | 2015-02-03 | 1,392,094 | — | $0 | 1,392,094 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | P Buy | 2014-03-12 | 2015-02-03 | 272,727 | $11.00 | $3.00M | 1,664,821 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | C Conversion deriv | 2014-03-12 | 2014-03-12 | 170,454 | — | $0 | 0 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | C Conversion deriv | 2014-03-12 | 2014-03-12 | 293,884 | — | $0 | 0 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | C Conversion deriv | 2014-03-12 | 2014-03-12 | 292,532 | — | $0 | 0 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | C Conversion deriv | 2014-03-12 | 2014-03-12 | 255,681 | — | $0 | 0 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | C Conversion deriv | 2014-03-12 | 2014-03-12 | 379,543 | — | $0 | 0 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | C Conversion | 2014-03-12 | 2014-03-12 | 1,392,094 | — | $0 | 1,392,094 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | C Conversion deriv | 2014-02-10 | 2014-02-11 | 351,866 | — | $0 | 0 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | C Conversion deriv | 2014-02-10 | 2014-02-11 | 827,917 | — | $0 | 0 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | C Conversion | 2014-02-10 | 2014-02-11 | 1,388,645 | — | $0 | 1,388,645 | SEC↗ |